These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 7314992)

  • 1. [Principles for the conservative drug therapy treatment of prostate cancer].
    Hofmann W
    Z Urol Nephrol; 1981 Sep; 74(9):697-704. PubMed ID: 7314992
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aspects for hormone therapy in prostate cancer].
    Gorski J; Böhm WD; Kelly LU
    Z Urol Nephrol; 1981 Sep; 74(9):635-41. PubMed ID: 7314984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine therapy for advanced stage D prostate cancer.
    Taylor TK
    Urol Nurs; 1991 Sep; 11(3):22-6. PubMed ID: 1833823
    [No Abstract]   [Full Text] [Related]  

  • 4. Total androgen suppression in the management of prostatic cancer. A critical review.
    Schroeder FH
    Prog Clin Biol Res; 1985; 185A():307-17. PubMed ID: 3898133
    [No Abstract]   [Full Text] [Related]  

  • 5. Castration-resistant prostate cancer--hormone therapy redux.
    Tolcher AW; Cooper J
    J Clin Oncol; 2010 Mar; 28(9):1447-9. PubMed ID: 20159817
    [No Abstract]   [Full Text] [Related]  

  • 6. [New possibilities in the hormonal therapy of metastatic carcinoma of the prostate].
    Cicin-Sain D; Pasini J
    Lijec Vjesn; 1989 Nov; 111(11):405-7. PubMed ID: 2699907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of estrogen-resistant forms of cancer of the prostate].
    Marinbakh EB; Ar'e VM
    Urol Nefrol (Mosk); 1974; 39(4):68-74. PubMed ID: 4606039
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-prostatic androgen levels during various androgen-blockade regimens.
    Nishiyama T
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):229-41. PubMed ID: 18471782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative approaches to the hormonal treatment of advanced prostate cancer.
    Trachtenberg J
    Eur Urol; 1997; 32 Suppl 3():78-80. PubMed ID: 9267790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug treatment of prostatic carcinoma].
    Witjes JA; Debruyne FM
    Ned Tijdschr Geneeskd; 1997 Sep; 141(39):1855-8. PubMed ID: 9545743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New perspectives in the drug therapy of hormone-resistant prostate cancer].
    Vorob'ev NA; Nosov AK; Vorob'ev AV; Moiseenko VM
    Vopr Onkol; 2010; 56(6):645-53. PubMed ID: 21395118
    [No Abstract]   [Full Text] [Related]  

  • 12. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].
    Matveev BP; Bukharkin BV
    Vopr Onkol; 1998; 44(5):537-40. PubMed ID: 9884710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatment of advanced prostate cancer.
    Ismail M; Gomella LG
    Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel concepts in androgen receptor blockade.
    Hsieh AC; Ryan CJ
    Cancer J; 2008; 14(1):11-4. PubMed ID: 18303477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Castration of prostate cancer patients and cognition].
    Portin R; Koskinen A; Helenius H; Nurmi M; Salminen E
    Duodecim; 2005; 121(16):1784-5. PubMed ID: 16268226
    [No Abstract]   [Full Text] [Related]  

  • 16. New drugs in the management of advanced prostate cancer.
    Kelly WK
    Cancer J; 2008; 14(1):10. PubMed ID: 18303476
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant treatment of prostatic carcinoma after primary therapy. The "Early Prostate Cancer" Program].
    Mansueto G; Longo F
    Recenti Prog Med; 2002 Mar; 93(3):175-8. PubMed ID: 11942169
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition by antiandrogens of the prostatic growth stimulated by adrenal androgens and pituitary prolactin in castrate rats.
    Walsh PC; Gittes RF
    Surg Forum; 1969; 20():518-9. PubMed ID: 4315509
    [No Abstract]   [Full Text] [Related]  

  • 19. New agents in metastatic prostate cancer.
    Fizazi K; Massard C
    Eur J Cancer; 2009 Sep; 45 Suppl 1():379-80. PubMed ID: 19775638
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of hormonal profile in adjusting therapy for prostate cancer].
    Granov AM; Molchanov OE; Karelin MI
    Vopr Onkol; 2008; 54(4):457-62. PubMed ID: 18942400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.